These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 11579438)

  • 1. Vancomycin, teicoplanin, and ramoplanin: synthetic and mechanistic studies.
    Boger DL
    Med Res Rev; 2001 Sep; 21(5):356-81. PubMed ID: 11579438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The in vitro activity of ramoplanin (A-16686/MDL 62,198), vancomycin and teicoplanin against methicillin-susceptible and methicillin-resistant Staphylococcus spp.
    O'Hare MD; Felmingham D; Grüneberg RN
    Drugs Exp Clin Res; 1988; 14(10):617-9. PubMed ID: 2977587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In-vitro activity of ramoplanin (a novel lipoglycopeptide), vancomycin, and teicoplanin against gram-positive clinical isolates from cancer patients.
    Rolston KV; Dholakia N; Ho DH; LeBlanc B; Dvorak T; Streeter H
    J Antimicrob Chemother; 1996 Aug; 38(2):265-9. PubMed ID: 8877541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative in-vitro activity of vancomycin, teicoplanin, ramoplanin (formerly A16686), paldimycin, DuP 721 and DuP 105 against methicillin and gentamicin resistant Staphylococcus aureus.
    Maple PA; Hamilton-Miller JM; Brumfitt W
    J Antimicrob Chemother; 1989 Apr; 23(4):517-25. PubMed ID: 2526111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activities of ramoplanin, selected glycopeptides, fluoroquinolones, and other antibiotics against clinical bloodstream isolates of gram-positive cocci.
    Lawrence T; Rotstein C; Beam TR; Gorzynski EA; Amsterdam D
    Antimicrob Agents Chemother; 1993 Apr; 37(4):896-900. PubMed ID: 8494388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemistry and biology of the ramoplanin family of peptide antibiotics.
    McCafferty DG; Cudic P; Frankel BA; Barkallah S; Kruger RG; Li W
    Biopolymers; 2002; 66(4):261-84. PubMed ID: 12491539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In-vitro activity of vancomycin, teicoplanin, daptomycin, ramoplanin, MDL 62873 and other agents against staphylococci, enterococci and Clostridium difficile.
    Bartoloni A; Colao MG; Orsi A; Dei R; Giganti E; Parenti F
    J Antimicrob Chemother; 1990 Nov; 26(5):627-33. PubMed ID: 1688341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activities of ramoplanin and four glycopeptide antibiotics against clinical isolates of Clostridium difficile.
    Biavasco F; Manso E; Varaldo PE
    Antimicrob Agents Chemother; 1991 Jan; 35(1):195-7. PubMed ID: 1826593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activities of ramoplanin, teicoplanin, vancomycin, linezolid, bacitracin, and four other antimicrobials against intestinal anaerobic bacteria.
    Citron DM; Merriam CV; Tyrrell KL; Warren YA; Fernandez H; Goldstein EJ
    Antimicrob Agents Chemother; 2003 Jul; 47(7):2334-8. PubMed ID: 12821492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the glycopeptide framework in the antibacterial activity of hydrophobic derivatives of glycopeptide antibiotics.
    Printsevskaya SS; Pavlov AY; Olsufyeva EN; Mirchink EP; Preobrazhenskaya MN
    J Med Chem; 2003 Mar; 46(7):1204-9. PubMed ID: 12646030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro bactericidal activity of the glycopeptide compounds vancomycin, teicoplanin and ramoplanin (A-16686/MDL 62,198).
    O'Hare MD; Felmingham D; Grüneberg RN
    J Chemother; 1989 Jul; 1(4 Suppl):210-1. PubMed ID: 16312373
    [No Abstract]   [Full Text] [Related]  

  • 12. In-vitro studies with ramoplanin (MDL 62,198): a novel lipoglycopeptide antimicrobial.
    O'Hare MD; Ghosh G; Felmingham D; Grüneberg RN
    J Antimicrob Chemother; 1990 Feb; 25(2):217-20. PubMed ID: 2139436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Susceptibility of Clostridium difficile strains to teicoplanin and ramoplanin].
    Dworczyński A; Martirosian G; Meisel-Mikołajczyk F
    Med Dosw Mikrobiol; 1993; 45(4):483-6. PubMed ID: 8189828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and study of antibacterial activities of antibacterial glycopeptide antibiotics conjugated with benzoxaboroles.
    Printsevskaya SS; Reznikova MI; Korolev AM; Lapa GB; Olsufyeva EN; Preobrazhenskaya MN; Plattner JJ; Zhang YK
    Future Med Chem; 2013 Apr; 5(6):641-52. PubMed ID: 23617428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and evaluation of methyl ether derivatives of the vancomycin, teicoplanin, and ristocetin aglycon methyl esters.
    McComas CC; Crowley BM; Hwang I; Boger DL
    Bioorg Med Chem Lett; 2003 Sep; 13(17):2933-6. PubMed ID: 14611861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipophilic teicoplanin pseudoaglycon derivatives are active against vancomycin- and teicoplanin-resistant enterococci.
    Szűcs Z; Bereczki I; Csávás M; Rőth E; Borbás A; Batta G; Ostorházi E; Szatmári R; Herczegh P
    J Antibiot (Tokyo); 2017 May; 70(5):664-670. PubMed ID: 28144040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ramoplanin at bactericidal concentrations induces bacterial membrane depolarization in Staphylococcus aureus.
    Cheng M; Huang JX; Ramu S; Butler MS; Cooper MA
    Antimicrob Agents Chemother; 2014 Nov; 58(11):6819-27. PubMed ID: 25182650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Activity of vancomycin and teicoplanin against clinical isolates of Staphylococcus aureus in the period 1994-1999].
    Nashev D; Toshkova K; Gavrilova V
    Vutr Boles; 2000; 32(2):35-40. PubMed ID: 11227664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro antimicrobial susceptibility of glycopeptide-resistant enterococci.
    Freeman C; Robinson A; Cooper B; Mazens-Sullivan M; Quintiliani R; Nightingale C
    Diagn Microbiol Infect Dis; 1995 Jan; 21(1):47-50. PubMed ID: 7789096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First and second generation total synthesis of the teicoplanin aglycon.
    Boger DL; Kim SH; Mori Y; Weng JH; Rogel O; Castle SL; McAtee JJ
    J Am Chem Soc; 2001 Mar; 123(9):1862-71. PubMed ID: 11456806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.